ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 60 filers reported holding ONCOCYTE CORP in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $9,315 | -35.1% | 40,500 | 0.0% | 0.00% | -42.9% |
| Q1 2023 | $14,353 | +10.4% | 40,500 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $12,996 | -64.9% | 40,500 | -20.6% | 0.01% | -69.6% |
| Q3 2022 | $37,000 | -15.9% | 51,000 | +4.1% | 0.02% | -11.5% |
| Q2 2022 | $44,000 | -39.7% | 49,000 | 0.0% | 0.03% | -23.5% |
| Q1 2022 | $73,000 | -22.3% | 49,000 | +12.6% | 0.03% | -12.8% |
| Q4 2021 | $94,000 | – | 43,500 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWM Investment Company, Inc. | 719,282 | $2,359,245 | 0.35% |
| Defender Capital, LLC. | 114,520 | $357,302 | 0.13% |